{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:08:44Z","timestamp":1774494524982,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.01.021","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T10:55:26Z","timestamp":1708080926000},"page":"1812-1825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-5691","authenticated-orcid":false,"given":"Sonali","family":"Kochhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8941-6170","authenticated-orcid":false,"given":"David N.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5760-3836","authenticated-orcid":false,"given":"Cara","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-9790","authenticated-orcid":false,"given":"Hector S.","family":"Izurieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-8031","authenticated-orcid":false,"given":"Luigi","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1003-066X","authenticated-orcid":false,"given":"Alma","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Nordenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane F.","family":"Gidudu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-7856","authenticated-orcid":false,"given":"Erin F.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.021_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.851","article-title":"The Brighton Collaboration: enhancing comparability of vaccine safety data","volume":"12","author":"Kohl","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2024.01.021_b0010","series-title":"Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology)","article-title":"The Brighton Collaboration: Creating a global standard for case definitions (and guidelines) for adverse events following immunization","author":"Kohl","year":"2005"},{"key":"10.1016\/j.vaccine.2024.01.021_b0015","doi-asserted-by":"crossref","first-page":"8409269","DOI":"10.1155\/2022\/8409269","article-title":"De Novo autoimmune hepatitis after COVID-19 infection in an unvaccinated patient","volume":"2022","author":"Durazo","year":"2022","journal-title":"Case Reports Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102874","article-title":"Autoimmune hepatitis following COVID-19 vaccination","volume":"132","author":"Izagirre","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0025","doi-asserted-by":"crossref","first-page":"1190367","DOI":"10.3389\/fphar.2023.1190367","article-title":"COVID-19 vaccination-related autoimmune hepatitis-a perspective","volume":"14","author":"Sergi","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5582\/ddt.2023.01022","article-title":"Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases","volume":"17","author":"Wang","year":"2023","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.vaccine.2024.01.021_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.vaccine.2024.01.021_b0050","article-title":"Etiopathogenesis and diagnostic strategies in autoimmune hepatitis","volume":"11","author":"Domerecka","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.vaccine.2024.01.021_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.301","article-title":"Autoimmune hepatitis: Histopathology","volume":"3","author":"Geller","year":"2014","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.vaccine.2024.01.021_b0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.15386\/mpr-1228","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989\u20132016","volume":"92","author":"Valean","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0070","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","author":"Slooter","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2024.01.021_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2024.01.021_b0080","unstructured":"Linzay CD, Sharma B, Pandit S. Autoimmune hepatitis. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC.; 2023."},{"key":"10.1016\/j.vaccine.2024.01.021_b0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0100","article-title":"Autoimmune hepatitis following Epstein-Barr virus infection","volume":"2008","author":"Cabibi","year":"2008","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0105","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.3748\/wjg.v20.i35.12372","article-title":"Extrahepatic immune related manifestations in chronic hepatitis C virus infection","volume":"20","author":"Tampaki","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2024.01.021_b0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41584-023-00964-y","article-title":"High risk of autoimmune diseases after COVID-19","volume":"19","author":"Sharma","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0120","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.021_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102524","article-title":"Could SARS-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects?","volume":"19","author":"Caso","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2024.01.021_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?","volume":"123","author":"Ghielmetti","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0135","first-page":"528","article-title":"Autoimmune hepatitis associated with COVID-19 infection - a diagnostic and therapeutic dilemma","volume":"73","author":"Rajendiran","year":"2020","journal-title":"S D Med"},{"key":"10.1016\/j.vaccine.2024.01.021_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102688","article-title":"Auto-immune hepatitis following COVID vaccination","volume":"123","author":"Rela","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110345","article-title":"The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals","volume":"145","author":"Ca\u00f1as","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.vaccine.2024.01.021_b0160","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/hep4.1979","article-title":"Immune-mediated liver injury following COVID-19 vaccination: A systematic review","volume":"6","author":"Roy","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0165","doi-asserted-by":"crossref","first-page":"1035073","DOI":"10.3389\/fimmu.2022.1035073","article-title":"Autoimmune hepatitis after COVID-19 vaccination","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0170","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2024.01.021_b0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.13.21","article-title":"Autoimmune hepatitis in diverse ethnic populations and geographical regions","volume":"7","author":"Czaja","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J Dig Dis"},{"key":"10.1016\/j.vaccine.2024.01.021_b0190","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0195","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0200","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0205","doi-asserted-by":"crossref","first-page":"e0239964","DOI":"10.1371\/journal.pone.0239964","article-title":"Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa","volume":"15","author":"Afaa","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.01.021_b0210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0215","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence and mortality of autoimmune hepatitis in England 1997\u20132015. A population-based cohort study","volume":"40","author":"Gr\u00f8nbaek","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2024.01.021_b0220","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s10620-022-07728-w","article-title":"Missing causality and heritability of autoimmune hepatitis","volume":"68","author":"Czaja","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0225","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s10620-023-07967-5","article-title":"Incorporating the molecular mimicry of environmental antigens into the causality of autoimmune hepatitis","volume":"68","author":"Czaja","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413578","article-title":"Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms","volume":"22","author":"Sirbe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0235","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clinre.2019.02.007","article-title":"Development of autoimmune hepatitis after influenza vaccination; trigger or killer?","volume":"43","author":"Muratori","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0240","doi-asserted-by":"crossref","first-page":"e11621","DOI":"10.1097\/MD.0000000000011621","article-title":"Autoimmune hepatitis following influenza virus vaccination: Two case reports","volume":"97","author":"Sasaki","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2024.01.021_b0245","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3748\/wjg.v13.i15.2238","article-title":"Hepatitis A vaccine associated with autoimmune hepatitis","volume":"13","author":"Berry","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0029-1233537","article-title":"Vaccination as a triggering event for autoimmune hepatitis","volume":"29","author":"Perumalswami","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.vaccine.2024.01.021_b0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/00365521.2016.1224379","article-title":"Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review","volume":"52","author":"van Gemeren","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0260","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1016\/j.vaccine.2011.05.002","article-title":"Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl","volume":"29","author":"Della Corte","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.021_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional immune regulation in autoimmune hepatitis: from pathogenesis to novel therapies","volume":"12","author":"Vuerich","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40246-020-00301-4","article-title":"Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response","volume":"15","author":"Higuchi","year":"2021","journal-title":"Hum Genomics"},{"key":"10.1016\/j.vaccine.2024.01.021_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.921765","article-title":"Epigenetic aspects and prospects in autoimmune hepatitis","volume":"13","author":"Czaja","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0280","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/LVT.0000000000000105","article-title":"Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America","volume":"29","author":"Enke","year":"2023","journal-title":"Liver Transpl"},{"key":"10.1016\/j.vaccine.2024.01.021_b0285","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0295","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2024.01.021_b0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.021_b0305","article-title":"Approach to the patient with acute severe autoimmune hepatitis","volume":"2","author":"Rahim","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0310","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0315","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2024.01.021_b0320","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0330","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2024.01.021_b0335","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","author":"Heringlake","year":"2009","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0345","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0350","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0355","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0360","article-title":"Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis","volume":"3","author":"Laschtowitz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0365","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2024.01.021_b0370","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2024.01.021_b0380","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/flgastro-2018-101015","article-title":"Autoimmune hepatitis and complexities in management","volume":"10","author":"Janmohamed","year":"2019","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0390","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.01.021_b0395","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0400","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.01.021_b0405","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0410","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3748\/wjg.v28.i24.2654","article-title":"Drug-induced autoimmune hepatitis: A minireview","volume":"28","author":"Tan","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0415","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.021_b0420","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2020.12.024","article-title":"Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed","volume":"85","author":"Rigopoulou","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vaccine.2024.01.021_b0425","first-page":"12","article-title":"Wilson's disease presentation resembling autoimmune hepatitis","author":"Santos","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mpdhp.2022.10.003","article-title":"Pathologic features and differential diagnosis of chronic hepatitis","volume":"29","author":"Choi","year":"2023","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0435","first-page":"1003","article-title":"Causes and evaluation of mildly elevated liver transaminase levels","volume":"84","author":"Oh","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.vaccine.2024.01.021_b0440","article-title":"Association of autoimmune hepatitis and celiac disease: role of gluten-free diet in reversing liver dysfunction","volume":"5","author":"Iqbal","year":"2017","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.vaccine.2024.01.021_b0445","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/127589","article-title":"Celiac disease and autoimmune-associated conditions","volume":"2013","author":"Lauret","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2024.01.021_b0450","first-page":"100","article-title":"Thyroid dysfunction is prevalent in autoimmune hepatitis: a case control study","volume":"22","author":"Khoury","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2024.01.021_b0455","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-021-08888-9","article-title":"Autoimmune hepatitis: serum autoantibodies in clinical practice","volume":"63","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0460","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.pcl.2021.07.006","article-title":"Pediatric autoimmune liver diseases: autoimmune hepatitis and primary sclerosing cholangitis","volume":"68","author":"Kemme","year":"2021","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2024.01.021_b0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bpobgyn.2020.03.007","article-title":"Autoimmune hepatitis and pregnancy","volume":"68","author":"Braga","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2024.01.021_b0470","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/hep.32410","article-title":"Autoimmune hepatitis in pregnancy: Pearls and pitfalls","volume":"76","author":"Chung","year":"2022","journal-title":"Hepatology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:33:21Z","timestamp":1759404801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24000215"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}